Home / Deep Research / Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome

Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome

Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome: Mechanistic Summary

2026-04-14
Manual MONDO:0007201 Model: n/a 7 citations

Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome: Mechanistic Summary

Disease-root framing

BPES is best curated as a disease root with subtype structure, not as a flat eyelid phenotype bucket. Recent clinical review data explicitly separate BPES-I from BPES-II by the presence or absence of primary ovarian insufficiency (PMID:41555764). Review literature also emphasizes that both subtypes share the same congenital eyelid complex and that genotype alone does not fully determine subtype assignment (PMID:33806295).

Genetics and inheritance

BPES is a predominantly autosomal dominant disorder caused by heterozygous pathogenic variants in FOXL2 (PMID:33806295; PMID:20301614). FOXL2 is the single causal anchor for the classic root disease and should be modeled as the causative gene in the disorder entry.

Core pathophysiology

Two mechanistic axes repeatedly emerge from the literature:

  1. Eyelid developmental dysregulation FOXL2 variants impair transcriptional control of eyelid-development targets. Functional data show failure of mutant FOXL2 proteins to transactivate OSR2, which is consistent with the eyelid malformation phenotype (PMID:33796131).

  2. Ovarian reserve maintenance failure in Type I FOXL2 dysfunction also affects ovarian biology. Functional assays show loss of FOXL2 repression on CYP19A1 and CCND2 promoters (PMID:31823134), and clinical cohorts demonstrate diminished ovarian reserve with adverse assisted reproductive technology outcomes in FOXL2-mutant BPES women (PMID:35574016).

Variant class influences severity but does not create a deterministic rule. Truncating FOXL2 variants are enriched in BPES-I, whereas polyalanine-region changes are more often associated with BPES-II (PMID:41555764; PMID:33806295).

Hallmark phenotypes

The four cardinal BPES features present at birth are:

  • Blepharophimosis
  • Ptosis
  • Epicanthus inversus
  • Telecanthus

These are explicitly defined in GeneReviews (PMID:20301614). Associated ocular features include strabismus, refractive errors, and amblyopia (PMID:20301614). Type I additionally carries primary ovarian insufficiency and female infertility risk (PMID:20301614; PMID:31823134).

Treatment-relevant findings

Management is multidisciplinary and naturally separates into ocular and reproductive domains:

  • Staged eyelid surgery: medial canthoplasty for blepharophimosis, epicanthus inversus, and telecanthus, followed later by ptosis correction (PMID:20301614).
  • Frontalis suspension / canthoplasty approaches: clinical series support staged canthoplasty plus frontalis suspension for correction of epicanthus, telecanthus, and coexisting blepharoptosis (PMID:35590300).
  • Hormone replacement therapy for BPES-I-associated ovarian insufficiency (PMID:20301614).
  • Assisted reproductive technology and fertility planning for affected women with FOXL2 mutations, though outcomes are heterogeneous (PMID:35574016; PMID:20301614).

References